Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

This Article Full Text (PDF, 654K) PPT slides of all figures Alert me when this article is cited Services Email this article Similar articles in this journal Alert me to new content in the JEM Download to citation manager Citing Articles Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Van Epps, H. L. Search for Related Content PubMed Articles by Van Epps, H. L. Related Collections Related Article Social Bookmarking                            What's this?

Mature secretory vesicles (arrows) are missing in the absence of the phosphatase MEG2.

Cellular constipation can be deadly, according to a study on page 1587. Wang and colleagues show that cells get clogged with aborted secretory cargo when they lack an enzyme that helps form vesicles. Deletion of this enzyme proved lethal in mice, halting brain, bone and vascular development.

The enzyme in question is a protein tyrosine phosphatase (PTP) called MEG2. MEG2 binds lipids and resides on intracellular vesicle membranes, where it clips phosphate residues from the fusion protein NSF. Once dephosphorylated, NSF initiates homotypic fusion between immature secretory vesicles, a critical step in protein secretion.

Knocking out MEG2, the team found, prevented T cells (isolated from chimeric mice) from secreting the autocrine growth factor interleukin-2, stunting T cell proliferation in response to stimulation. Electron micrographs of the deficient T cells revealed that the cells lacked mature secretory vesicles and were clogged with the dense remains of fusion-incompetent vesicles.

Platelets that lacked MEG2 were also dysfunctional, failing to aggregate when exposed to the clotting factor thrombin. But the MEG2 defect spared neutrophils and macrophages, although these cells rely on the same cellular machinery for vesicle release.

Cell type–specific PTPs might compensate for MEG2's absence in neutrophils and macrophages. Besides looking for these PTPs, the group is also investigating the mechanism behind the developmental defects in the MEG2-deficient mice, which they suspect result from an inability to produce growth factors that direct the migration and differentiation of progenitor cells.

hvanepps{at}rockefeller.edu

CiteULike    Complore    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?

Related Article

Tyrosine phosphatase MEG2 modulates murine development and platelet and lymphocyte activation through secretory vesicle function

Yingchun Wang, Eric Vachon, Jinyi Zhang, Vera Cherepanov, Joshua Kruger, Jun Li, Kan Saito, Patrick Shannon, Nunzio Bottini, Huong Huynh, Heyu Ni, Hong Yang, Colin McKerlie, Sue Quaggin, Zhizhuang Joe Zhao, Philip A. Marsden, Tomas Mustelin, Katherine A. Siminovitch, and Gregory P. Downey
J. Exp. Med. 2005 202: 1587-1597. [Abstract] [Full Text] [PDF]

This Article Full Text (PDF, 654K) PPT slides of all figures Alert me when this article is cited Services Email this article Similar articles in this journal Alert me to new content in the JEM Download to citation manager Citing Articles Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Van Epps, H. L. Search for Related Content PubMed Articles by Van Epps, H. L. Related Collections Related Article Social Bookmarking                            What's this?